U.S. flag

An official website of the United States government

NM_000261.2(MYOC):c.1111T>G (p.Tyr371Asp) AND Glaucoma of childhood

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 2, 2023
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003226020.1

Allele description [Variation Report for NM_000261.2(MYOC):c.1111T>G (p.Tyr371Asp)]

NM_000261.2(MYOC):c.1111T>G (p.Tyr371Asp)

Gene:
MYOC:myocilin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q24.3
Genomic location:
Preferred name:
NM_000261.2(MYOC):c.1111T>G (p.Tyr371Asp)
Other names:
NM_000261.2:c.1111T>G
HGVS:
  • NC_000001.11:g.171636329A>C
  • NG_008859.1:g.21305T>G
  • NM_000261.2:c.1111T>GMANE SELECT
  • NP_000252.1:p.Tyr371Asp
  • NC_000001.10:g.171605469A>C
Protein change:
Y371D
Molecular consequence:
  • NM_000261.2:c.1111T>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Glaucoma of childhood
Synonyms:
Childhood glaucoma; Infantile glaucoma; Pediatric glaucoma; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0020367; MedGen: C2981140; Human Phenotype Ontology: HP:0001087

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV003922088ClinGen Glaucoma Variant Curation Expert Panel
reviewed by expert panel

(ClinGen Glaucoma ACMG Specifications v1.1)		Uncertain significance
(May 2, 2023) 		germlinecuration

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Details of each submission

From ClinGen Glaucoma Variant Curation Expert Panel, SCV003922088.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The c.1111T>G variant in MYOC is a missense variant predicted to cause substitution of Tyrosine by Aspartic Acid at amino acid 371 (p.Tyr371Asp). This variant was not found in any population of gnomAD (v2.1.1), meeting the <=0.0001 threshold set for PM2_Supporting in a population of at least 10,000 alleles. The REVEL score = 0.892, which met the >=0.7 threshold for PP3, predicting a damaging effect on MYOC function. There was no functional evidence predicting a damaging or benign impact of this variant on MYOC function. 3 segregations in 1 family, with juvenile open angle glaucoma (JOAG), have been reported (PMID: 19784393), which fulfilled PP1 (3-4 meioses). Only 1 proband with JOAG had been reported (PMID: 19784393), not meeting the >=2 probands threshold required to meet PS4_Supporting. In summary, this variant met the criteria to receive a score of 3 and to be classified as a variant of uncertain significance (uncertain significance classification range -1 to 5) for juvenile open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v1, 12 Oct 2021): PP1, PP3, PM2_Supporting

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 13, 2023